Eric Wintemute Net Worth

The estimated Net Worth of Eric G Wintemute is at least $15.3 Milion dollars as of 29 August 2024. Mr. Wintemute owns over 100,000 units of American Vanguard stock worth over $5,444,954 and over the last 21 years he sold AVD stock worth over $7,888,609. In addition, he makes $1,954,940 as Chairman of the Board a Chief Executive Officer at American Vanguard.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Wintemute AVD stock SEC Form 4 insiders trading

Eric has made over 27 trades of the American Vanguard stock since 2003, according to the Form 4 filled with the SEC. Most recently he sold 100,000 units of AVD stock worth $572,000 on 29 August 2024.

The largest trade he's ever made was exercising 450,000 units of American Vanguard stock on 30 November 2012 worth over $1,651,500. On average, Eric trades about 17,229 units every 132 days since 2003. As of 29 August 2024 he still owns at least 897,027 units of American Vanguard stock.

You can see the complete history of Mr. Wintemute stock trades at the bottom of the page.

Eric Wintemute biography

Eric G. Wintemute serves as Chairman of the Board, Chief Executive Officer of the Company. Mr. Wintemute served as President and Chief Executive Officer (“CEO”) from July 1994 until June 2011, and Chairman and CEO since June 2011. With 26 years’ experience on this Board, 41 years’ experience at the Company (26 years as CEO) and membership in leading crop protection trade groups (current member of the board of directors and past chairman of CropLife America), Mr. Wintemute brings a broad industry perspective to the Board. From 2013 until 2018, Mr. Wintemute served as a member of the board of directors of TyraTech, Inc., during which time it was a publicly traded company on the London Stock Exchange. TyraTech, Inc. was acquired by the Company in November 2018 and delisted at that time. His interaction with the heads of the Company’s peers, suppliers and customers; legislators; and enforcement authorities has enabled him to identify economic, technological and political trends affecting the Company. He is an invaluable resource to the Board, particularly when evaluating future business plans, including acquisitions, and providing strategic direction to the Company.

What is the salary of Eric Wintemute?

As the Chairman of the Board a Chief Executive Officer of American Vanguard, the total compensation of Eric Wintemute at American Vanguard is $1,954,940. There are no executives at American Vanguard getting paid more.

How old is Eric Wintemute?

Eric Wintemute is 64, he's been the Chairman of the Board a Chief Executive Officer of American Vanguard since 2011. There are 8 older and 12 younger executives at American Vanguard. The oldest executive at American Vanguard Corp. is Alfred Ingulli, 78, who is the Independent Director.

What's Eric Wintemute's mailing address?

Eric's mailing address filed with the SEC is 4695 MACARTHUR COURT, STE 1200, , NEWPORT BEACH, CA, 92660.

Insiders trading at American Vanguard

Over the last 21 years, insiders at American Vanguard have traded over $50,676,664 worth of American Vanguard stock and bought 629,726 units worth $5,875,021 . The most active insiders traders include Glenn A Wintemute, Eric G Wintemute a Herbert A Kraft. On average, American Vanguard executives and independent directors trade stock every 29 days with the average trade being worth of $98,474. The most recent stock trade was executed by Keith M Cruiser Capital Adv... on 30 August 2024, trading 136,492 units of AVD stock currently worth $790,289.

What does American Vanguard do?

american vanguard corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the united states and internationally. the company manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection. it also markets and distributes end-use chemical and biological products for crop applications; distributes chemicals for greenhouse and nursery production markets; and offers formulations, such as pcnb, chlorothalonil, and propiconazole under the ffii and ffiii names. the company distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors. american vanguard corporation was founded in 196

Complete history of Mr. Wintemute stock trades at American Vanguard

American Vanguard executives and stock owners

American Vanguard executives and other stock owners filed with the SEC include:

• Eric Wintemute,
  Chairman of the Board, Chief Executive Officer
• Eric G. Wintemute,
  Chairman & CEO
• David Johnson,
  Chief Financial Officer, Vice President, Treasurer
• Ulrich Trogele,
  Executive Vice President, Chief Operating Officer of AMVAC Chemical Corporation
• Timothy Donnelly,
  Chief Administrative Officer, General Counsel, Secretary
• Dr. Ulrich G. Trogele Ph.D.,
  COO & Exec. VP
• Peter Eilers,
  Managing Director, Amvac Netherlands BV
• Timothy J. Donnelly Esq.,
  Gen. Counsel, Chief Admin. Officer & Sec.
• David T. Johnson,
  VP, CFO & Treasurer
• Anthony Hendrix,
  Senior Vice President - Crop Sales for U.S. & Canada
• Timothy J. Donnelly,
  Gen. Counsel, Chief Admin. Officer & Sec.
• Peter E. Eilers,
  Managing Director of AMVAC Netherlands BV
• Anthony Hendrix,
  Sr. VP of Crop Sales for U.S. & Canada
• John Killmer,
  Lead Independent Director
• Alfred Ingulli,
  Independent Director
• Morton Erlich,
  Independent Director
• Lawrence Clark,
  Independent Director
• M. Esmail Zirakparvar,
  Independent Director
• Scott Baskin,
  Independent Director
• Debra Edwards,
  Independent Director
• Emer Gunter,
  Independent Director
• William Kuser,
  Director of Investor Relations
• James Thompson,
  Director of Bus. Devel., Portfolio Management Biologicals & Non-Crop
• Robert F. Gilbane,
  Pres of Gemchem Inc
• Smith Cindy Baker,
  See Remarks
• Jong Ad De,
  MD AMVAC Netherlands BV
• John Rizzi,
  VP Operations (AMVAC)
• Anne Turnbough,
  See Remarks
• Steven D Macicek,
  
• Suneet Ranganath,
  See Remarks
• Peter Porpiglia,
  See Remarks
• Jean Pougnier,
  VP Business Dev. & Marketing
• Brett R Meinsen,
  VICE PRESIDENT
• Mark H Blincoe,
  VP/Chief Adm. Officer
• Jay R Harris,
  Director
• Carl R Soderlind,
  Director
• Keith M Cruiser Capital Adv...,
  
• James Lehman,
  Vice Pres of Sales Amvac Chem
• Glen D Johnson,
  Sr.VP AMVAC Chem. Corp.
• Jerome L Coben,
  Director
• Irving J Thau,
  Director
• Herbert A Kraft,
  Director
• Glenn A Wintemute,
  Director
• Trevor Thorley,
  COO & EVP of Amvac Chemical
• James A Barry,
  Sr. VP, CFO & Sec/Trsr
• Robert F Gilbane,
  President of GemChem, Inc.
• Christopher Hildreth,
  Sr. VP of AMVAC Chemical Corp.
• John B Miles,
  Director
• Doug Ashmore,
  VICE PRESIDENT MFG- AMVAC
• Johann Venter,
  See Remarks
• Patrick E Gottschalk,
  
• Marisol Angelini,
  
• Shayne M Wetherall,
  CEO, AMGUARD
• Andrew B Naughton,
  V.P., Director of Technology
• Keith M Rosenbloom,
  
• Mark R Bassett,
  
• John Mason Bennett,
  VP US Crop Sales